Необязательная аналитика продукта
С вашего разрешения мы используем ограниченную аналитику с защитой конфиденциальности, чтобы понять, какие исследовательские сценарии работают. Мы не используем рекламные трекеры или запись сеансов. Этот выбор можно изменить в настройках. Прочитайте Политику конфиденциальности.
Hormel Foods Corporation's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $11.5B |
|---|
| Revenue (ttm) | 12.1B |
|---|
| Net income (ttm) | 342.7M |
|---|
| EPS (ttm) | $0.62 |
|---|
| Shares out | 550.4M |
|---|
| P/E (trailing) | 33.2x |
|---|
| P/E (forward) | 13.4x |
|---|
| Dividend | $1.17 (5.68%) |
|---|
| Volume | 2,117,989 |
|---|
| Beta | 0.29 |
|---|
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-10-31 | 2022-10-30 | 2023-10-29 | 2024-10-27 | 2025-10-26 | Trend |
| Revenue | $11.39B | $12.46B | $12.11B | $11.92B | $12.11B | +1.5% |
| Gross profit | $1.93B | $2.16B | $2.00B | $2.02B | $1.89B | -0.5% |
| Operating income | $1.12B | $1.31B | $1.07B | $1.07B | $718.6M | -10.6% |
| Net income | $908.8M | $1,000.0M | $793.6M | $805.0M | $478.2M | -14.8% |
| EPS (diluted) | $1.66 | $1.82 | $1.45 | $1.47 | $0.87 | -14.9% |
| EBITDA | $1.38B | $1.58B | $1.34B | $1.37B | $1.01B | -7.6% |
| R&D | $33.6M | $34.7M | $33.7M | $36.1M | $35.2M | +1.2% |
| SG&A | $853.1M | $879.3M | $942.2M | $1.01B | $996.6M | +4.0% |
Recent company headlines from major financial publishers.
Gradual operating margin normalization from FY2025 trough toward historical levels supports dividend stability and steady cash flow expansion, delivering target $23.82 with probability 60.0% and return 14.4%. Disconfirmation would occur by FY2026 if operating margin fails to rebound or free cash flow remains below dividend payouts.
Foodservice expansion accelerates alongside input cost deflation across turkey and pork, lifting gross margins and driving operating margin recovery beyond historical baselines. This path reaches target $38.24 with probability 20.0% and return 83.6%. Disconfirmation would appear by FY2026 if wholesale protein costs spike again or restaurant foot traffic stalls.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 4.5% | $29.5 | $32.9 | $37.8 | $45.5 | $59.8 |
| 5.4% | $24.5 | $26.4 | $28.8 | $32.2 | $37.2 |
| 6.4% | $21.3 | $22.4 | $23.8 | $25.8 | $28.2 |
| 7.3% | $19.0 | $19.8 | $20.7 | $21.9 | $23.4 |
| 8.2% | $17.3 | $17.8 | $18.5 | $19.3 | $20.2 |
Upcoming earnings date and setup when available.
Рейтинг, который имело опубликованное в каждом месяце издание исследования. Рейтинг сравнивает цену на дату анализа со справедливой стоимостью; он не показывает, оправдалась ли оценка.
| Год | янв. | февр. | март | апр. | май | июнь | июль | авг. | сент. | окт. | нояб. | дек. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
